Safety of breast feeding during rituximab treatment in multiple sclerosis

BACKGROUND: There are limited data on the safety of breast feeding during rituximab therapy. Our objective is to determine exposure from breast feeding and biological effects of rituximab in breastfed infants. METHODS: In our case series of six mother–infant pairs, the nursing mothers with relapsing...

Descripción completa

Detalles Bibliográficos
Autores principales: Rød, Brit Ellen, Torkildsen, Øivind, Myhr, Kjell-Morten, Bø, Lars, Wergeland, Stig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763193/
https://www.ncbi.nlm.nih.gov/pubmed/35879056
http://dx.doi.org/10.1136/jnnp-2022-329545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763193/
https://www.ncbi.nlm.nih.gov/pubmed/35879056
http://dx.doi.org/10.1136/jnnp-2022-329545

Ejemplares similares